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Simarouba versicolor is popularly known as pau-paraiba. It belongs to the Simaroubaceae family and is 
found in the Northeast of São Paulo and in some parts of the states of Pará and Mato Grosso do Sul. It 
is known that this and other species from this genus have several activities: insecticides, anti-
inflammatory, antitumor, anthelmintic, among others. The effects of ethanolic extract of the bark of S. 
versicolor (Sv-EtOH) on the reproductive system of rats were investigated; also the influence of 
estrogenic and/or antiestrogenic activity, estrous cycle, pregnancy, lactation and offspring 
development was observed. In the experimental protocols with ethanolic extract of S. versicolor, the 
doses were 10, 20 and 40 mg/kg. To evaluate estrogenic and anti-estrogenic activity, uterotrophic assay 
and histopathology of the uterus were performed. In the estrous cycle tests, animals were treated daily, 
for 30 days, to count number of cycles and record the biochemical profile. During pre-implantation and 
post-implantation, the effect of the extract on pregnancy, lactation and development of the progeny was 
observed. Uterotrophic assay exhibited anti-estrogenic activity at extract doses of 10, 20 and 40 mg/kg. 
The animals exposed to all doses had no changes in their estrous cycle, pregnancy, lactation and 
biochemical profile. All results were within normal range; however, creatinine concentration increased 
significantly at all doses as compared to the control. The ethanol extract of S. versicolor presented 
antiestrogen activity, low systemic toxicity and had no reproductive toxicity at investigated doses. 
 





Medicinal plants are important and they supply raw 
materials to synthetize medicines, besides being used as 
therapeutics. The use of plants is overvalued traditionally 
based on their medicinal benefits, and often they are the 
only therapeutic resource of many communities and 
ethnic groups (Tresvenzol et al., 2006; Garcia et al., 
2010). Herbal remedies are often indiscriminately 








natural products are not harmful to health. Therefore, it is 
necessary to carry out toxicity studies with respect to this 
class of users. Thus, reproductive toxicity evaluation tests 
comprise the exposure of sexually mature animals before 
conception, during prenatal development and after birth 
(Lourenço et al., 2009). 
Among the commonly used plants, Simarouba 
versicolor, from Simaroubaceae family, stands out in folk 
medicine. Its bark and fruit are used as anthelmintic and 
the infusion of its bark has anti poisonous effect (Pires et 
al., 2006). Furthermore, they may be useful in the 
treatment of dyspepsia, diarrhea and fever. S. versicolor 
inhibits acetylcholinesterase enzyme (Carvalho, 2008), 
and causes an outbreak of cattle poisoning in Agua Clara 
County, Mato Grosso do Sul (Carvalho et al., 2013). 
Regarding its acute toxicity, Fernandes et al. (2004) 
determined the median lethal dose (DL50) of the aqueous 
extract of S. versicolor in mice; it was approximately 
185.88 and 68.80 mg/kg administered through oral and 
intraperitoneal routes, respectively. Mesquita (2009), 
studying an anticancer substance (glaucarubinona, 
extremely active on cancer cells) obtained from hexane 
extract of the bark and root of S. versicolor, saw that the 
substance gave significant results. 
Mesquita (1997), through chromatographic analysis of 
chloroform and ethyl acetate fractions removed from the 
wood of S. versicolor, isolated two quassinoids, excelsina 
and 11-ethyl-amarolídio, where excelsina was first 
isolated in this genus. Arriaga et al. (2002), through 
hexane, chloroform, ethyl acetate and methanol extracts, 
isolated a mixture of quassinoids triterpenoids and 
steroids, in addition to kaempferol flavonoid and 
squalenic derivatives from roots, branches and fruits of 
this plant. According to Almeida et al. (2007), quassinoids 
present in S. versicolor show a wide range of biological 
activities, such as antitumor, antimalarial, antioxidant, 
amebicides, antiviral and also a male anti-fertility, a fact 
that aroused the interest in studying S. versicolor effect 
on female reproduction. 
From this perspective, this study aimed to investigate 
the effects of S. versicolor bark ethanolic extract (Sv-
EtOH) on the reproductive system of rats, observing the 
influence of estrogenic and/or antiestrogenic activity, 
estrous cycle, pregnancy, lactation and progeny 
development, as well as the effects of this extract on 
biochemical profile, histologic and morphometric aspects 
of system reproductive female Wistar rats. 
 
 









the Central Biotherium of the Federal University of Piauí. Animals 
were kept in standard cages at controlled temperature (24 ± 1°C) in 
a 12 h light/dark cycle; there was free access to water and feed. 
Experimental protocols were approved by the Ethics Committee in 




Chemicals and drugs 
 
The following constituted the chemicals and drugs used in this 
study: dimethylsulfoxide (DMSO) - DYNAMIC, BRAZIL), estradiol 
cyprionate (Pfizer), Tamoxifen (DEG, CHINA), sodium thiopental 
and corn oil. For protocols application, the extract was diluted in 
DMSO and distilled water. 
 
 
Preparation of the ethanol extract 
 
Barks of S. versicolor were collected in Angical (6°05'41°28'), Piauí, 
Brazil. A voucher of the plant was identified and deposited in the 
Herbarium Graziela Barroso acquis (TEPB) of the Federal 
University of Piauí, Teresina, Piauí under number TEPB-20.883. It 
was dried in a forced air circulation drying oven for three days at 45 
± 1°C. After complete drying, the material was crushed in a Willi 
type mill. The ethanol extract was obtained by placing 1 kg of plant 
feedstock into ethanol for four days at room temperature in cold 
maceration followed by filtration. After four successive extractions, it 
was homogenized and placed in a rotary evaporator at 45 ± 1°C 
coupled to a thermostatic bath, followed by lyophilization. The 
ethanol extract lyophilized was diluted in dimethylsulfoxide and 





To uterotrophic assay, 100 immature Wistar rats (21 ± 1 postnatal 
day), weighing from 40 - 55 g, were divided into 10 groups of 10 
animals treated after 22 to 28 post-natal days (once per day). 
Treatments were performed according to Table 1, wherein the 
extract (Sv-EtOH) vehicle was distilled water and dimethyl sulfoxide 
(6%); for estradiol, it was corn oil and for tamoxifen, distilled water. 
After treatment, animals were euthanized with an overdose of 
sodium thiopental (100 mg/kg, ip). They had uterus and ovaries 
removed, dissected and weighed on an analytical balance (0.001g) 
and then Formalin fixed (10% buffered formaldehyde). After 24 h, 
organs were re-sectioned for histology processing: they were 
dehydrated with alcohol (70 to 100%), diaphanized in xylene, 
submitted to impregnation and included in paraffin. Tissue 
fragments were cut with 5.0 µM thickness in a microtome, stained 
with hematoxylin-eosin and examined by light microscopy. Uterine 
sections were submitted to morphometric analysis using 
computerized image analyzer (Qwin Leica D-1000, version 2.1.0: 
Cambridge, UK).  Five to six fields of uterine epithelium of each 
animal were captured and measured using Image-Pro Plus, version 
4.5.0 Windows 98/NT/200. 
 
 
Test involving estrous cycle 
 
To evaluate the effect of Sv-EtOH treatment on the estrous cycle of 
rats, 32 mice were randomly assigned into 4 groups of 8 animals of  
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Table 1. Experimental design of uterotrophic assay with ethanol extract of Simarouba versicolor in rats. 
 
Number Groups Dosage Routes of administration 
10 Negative control ( H2Od + DMSO) 10 mL/kg o.a. 
10 Sv-EtOH 10 10 mg/kg o.a. 
10 Sv-EtOH 20 20 mg/kg o.a. 
10 Sv-EtOH 40 40 mg/kg o.a. 
10 Estradiol 5 µg/kg i.m. 
10 Tamoxifen 4 mg/kg i.m 
10 Estradiol + Tamoxifen 5 µg/kg + 4 mg/kg o.a + i.m 
10 Sv-EtOH 10 + Estradiol 10 mg/kg + 5µg/kg o.a. + i.m 
10 Sv-EtOH 20 + Estradiol 20 mg/kg + 5µ/kg o.a. + i.m 
10 Sv-EtOH 40 + Estradiol 40 mg/kg + 5µ/kg o.a. + i.m 
 




Table 2. Experimental design of treatment with ethanol extract of S. versicolor to evaluate its effect on 
estrous cycle of female rats. 
 
Number Groups Dosage Routes of administration 
8 G1 - Control (H2Od + DMSO) 10 mL/kg o.a. 
8 G2 - Sv-EtOH 10 10 mg/kg o.a. 
8 G3 - Sv-EtOH 20 20 mg/kg o.a. 
8 G4 - Sv-EtOH 40 40 mg/kg o.a. 
 





90 days and weighing from 180 – 250 g, having regular estrous 
cycle. From the beginning of estrus, animals were treated for 30 
consecutive days according to the protocol outlined on Table 2. 
Daily, rats were submitted for vaginal lavage with saline solution 
of 0.9% (50 µL release and immediate recovery). Then, fresh 
confectioned smears were used to verify cycle phase. This was 
observed in light microscopy at 40x magnification. Phases were 
determined according to Hankness and Wagner (1993) (diestrus, 
proestrus; onset of estrus; end of estrus and meta-oestrus). Estrus 
visualization was considered as the starting point of each estrous 
cycle, which was recorded during each individual cycle phase.  
After treatment, animals were euthanized with sodium 
pentobarbital overdose (100 mg/kg, i.p.). Then, there was blood 
and serum collection, which was stored for later evaluation of the 
biochemical profile: glutamic oxalacetic transaminase (TGO), 
transaminase glutamic pyruvate (TGP), triglycerides, urea, 
creatinine, total cholesterol and total protein. Colorimetric method 








Nulliparous females were placed with adult males in the dark phase 
of the cycle consisting of 1 male for 2 females. In the morning after 
mating, vaginal lavage was performed looking for evidence of 
sperms. Smears were evaluated by optical microscopy (10 - 40x). 
The    presence   of   vaginal   plug   or   sperm   in  vaginal  washes 




Preimplantation period (1st to 7th day of pregnancy) 
 
In this protocol, 32 pregnant rats with 160-250 weights were divided 
into 4 groups of 8 animals. Rats were treated with extract (10, 20 
and 40 mg/kg) from the first to seventh day of pregnancy, as well 
the control group (distilled water and 6% DMSO/10 g body weight). 
During the treatment, animals were weighed daily. After eight days, 
progenitors were euthanized (sodium thiopental 100 mg/kg, ip), 
observing organ weights, pre-implant and visible signs of toxicity 
losses: piloerection, fur loss, shivers, salivation, convulsions, hypo 
activity, reduction of normal feed intake, weight loss, and presence 
of diarrhea. Liver, kidneys, adrenals, uterus and ovaries had their 
absolute masses weighed in analytical balance. 
Pre-implant losses were determined according to the following 
formula: pre-implant losses = (number of corpus luteum - number of 
implants/number of corpus luteum) × 100. Corpus luteum was 
counted with Lupa Olympus SZ40 and implants with naked eye. 
 
 
Gestational period (1st to 20th day of pregnancy)  
 
In this experiment, 32 pregnant rats, weighing 160-250 g, divided 
into 4 groups (n = 8) were housed in individual cages and treated 
daily from the first to the twentieth day of gestation with control 
(vehicle), SvEtOH 10, 20 and 40 mg/kg. 
Females’ weight  gain  was  evaluated  daily  and  extract  doses 




were adjusted. On the 20th day of gestation, females were 
anesthetized (ketamine 50 mg + xylazine 5 mg) and submitted to 
cesarean for removal and evaluation of the pregnant uterus and its 
contents. Fetuses and implantation sites were counted and 
weighed individually, so were gravid uterus, fetus and placenta. 
Fetuses were examined and analyzed macroscopically looking for 
anomalies and/or congenital malformations. After caesarian, 
animals were euthanized by overdose of anesthetic association (1 
mL/100 g/bw/ip) to remove and weigh the following organs: ovaries, 
liver, kidneys, spleen, heart, lung and adrenal glands, which had 
their relative masses calculated. Corpus luteum and implantations 
sites were counted. Reproductive parameters were evaluated using 
the following formulas: 
 
Implementation contents = (number of deployments/number of 
corpora luteum) x 100 
 
Resorption index = (number of resorption*/number of implants) x 
100 
 
*Number of resorption = (number implants) - (number of fetuses) 
 
Pre-implant losses = (number of corpus luteum - number of 
implants/number of corpus luteum) x 100 
 
Post-implant losses = (number of implants - number of 
births/number of implants) x 100 
 
Piloerection, fur loss, shivers, salivation, convulsions, hypo activity, 
reduction of normal feed intake, weight loss, abortion and presence 




Post-implantation, lactation and development of progeny 
period 
 
Pregnant rats divided into 4 groups of 5 animals, weighing 160- 
250, were treated once daily with 10, 20 and 40 mg/kg of Sv-EtOH 
and with the vehicle; administrations started on the 8th day of 
pregnancy, beginning of fetus post-implantation period. Treatment 
was stopped only on progeny birth (21 ± 1 day of pregnancy), and 
continued on the day after birth until the 21th day of lactation 
(weaning). 
On the 18th day of pregnancy, progenitors were separated into 
individual cages until delivery and inspected twice daily until 
offspring birth (1st postnatal day). On 21st postnatal day, pups were 
separated and placed in new cages (Muller et al., 2009) and 
progenitors were euthanized (Thiopental, 100 mg/kg/i.p.) for organ 
gathering. During pregnancy and breastfeeding were observed: 
weight gain, duration of pregnancy, birth rate, number of births, 
viability thereof, besides indicators of systemic toxicity (Muller et al., 
2013).  Birth delivery, birth rates and viability were determined 
according to US-EPA (1996) formulas: 
 
Childbirth index = (number of females who delivered/number of 
females with evidence of pregnancy) x 100 
 
Index birth = (number of births/number of litters) x 100 
 
Index viability = (number of live young on the fourth day post-
natal/number of live births) x 100 
 
Post-implant losses = (number of implants – number of 
births/number of implants) × 100 
 
Progeny was observed twice daily as the evolution of 
characteristics: emergence of fur (5 to 7 days), bilateral eyelid 











For tests conducted during pre and post-implantation periods, 
pregnancy and uterotrophic data were expressed as mean standard 
error of the mean (SEM). Statistical analyses were performed with 
Graphpad PRISM ® software, version 5.0, by ANOVA (One Way), 
followed by Tukey post-test; significance was set at p<0.05. 
Comparison of data in the same group was made by paired 
student's test with significance of p<0.05.  
Estrous cycle length data were analyzed and processed using 
SPSS (Statistical Package for Social Sciences) software for 
Windows, version 15. Initially, a descriptive analysis of the sample 
was done by calculating the average. Thereafter, Kolmogorov-
Smirnov test was applied to test the normality of the results. When 
the data set to compare the results met the requirements for 
applying parametric statistics, we used the parametric analysis of 
variance (ANOVA). When application of non-parametric statistics 
was necessary, comparison between groups was performed using 







Rats treated with SV-EtOH at all doses tested did not 
show any increase in relative masses of uterus, which is 
similar to negative control, that shows no estrogenic 
activity. On the other hand, the group treated with 
estradiol (positive control) showed a significant increase 
in the relative mass of uterus (p <0.05) as compared to 
negative control and treated group. 
Nevertheless, in anti-estrogenic activity test of females 
treated with Sv-EtOH and estradiol in all the doses, there 
was an inhibition of uterine growth and statistically 
significant differences (p <0.05) compared to animals 
treated only with estradiol (Figure 1). Their behavior was 
equal to groups treated with tamoxifen and tamoxifen + 
estradiol, which showed a significant inhibition (p <0.05) 
in uterine relative masses compared to those treated with 
estradiol. 
Histological evaluation of uterine epithelium in 
estrogenic activity tests showed that rats treated with 
estradiol had 90% eosinophilic inflammatory infiltration of 
mean intensity reaching muscular layer (Table 3 and 
Figure 1a). In contrast, animals treated with 10 and 20 
mg/kg of Sv-EtOH had a percentage less of eosinophilic 
infiltration (60 and 50%, respectively). Animals treated 
with 40 mg/kg presented 100% of eosinophilic infiltration 
in lamina propria with moderate intensity and swollen 
mucosal epithelial cells (Table 3). 
Antiestrogenic activity in the groups treated with Sv-
EtOH + estradiol at doses of 10 and 20 mg/kg (Figure 1d, 
e and 1f) revealed eosinophilic infiltration of moderate 
intensity reaching muscle layer with 90 and 100%, 
respectively. Different behavior was observed at 40 
mg/kg, which inhibited infiltration by 50% (Table 3). 






Figure 1. Photomicrographs showing longitudinal sections of the endometrium of rats: a, 
treated with estradiol (5μg); b, treated with tamoxifen (4 mg/kg); c, treated with estradiol + 




Table 3. Histopathological uterus of female rats treated with ethanolic extract of S. versicolor when compared with 
negative and positive controls in uterotrophic assay. 
 
Number Groups Uterus histopathology Percentage 
10 
Negative control (ad + 
DMSO) 
Normal 100 
10 Sv-EtOH 10  
Eosinophilic inflammatory infiltration of the 
lamina propria and muscle layer 
40 
    
10  Sv-EtOH 20   
Eosinophilic infiltrate of moderate intensity 
reaching the muscle layer 
50 
    
10  Sv-EtOH 40  
Eosinophilic infiltration of lamina propria of 
moderately severe intensity and swelling of 
epithelium cells mucosa 
100 
    
10 Estradiol 
Eosinophilic infiltration of moderate intensity 
reaching the muscle layer. 
90 
    
10 Tamoxifen Normal 100 
 




Table 3. Contd. 
 
10 Tamoxifen + Estradiol  
Eosinophilic inflammatory infiltrate of lamina 
propria and muscle layer. 
70 
    
10 Sv-EtOH 10 + Estradiol 
Eosinophilic inflammatory infiltrate of moderate 
intensity reaching the muscle layer 
90 
    
10 Sv-EtOH 20 + Estradiol 
Eosinophilic infiltration of the lamina propria of 
moderate moderately severe intensity reaching 
the muscle layer and swelling of the epithelial 
cells of the mucosa 
100 
    
10 Sv-EtOH 40 + Estradiol 
Eosinophilic infiltrate of moderate intensity 







Figure 2. Vaginal smears of rats treated with Sv-EtOH showing the four phases of estrous cycle 




Rats treated only with tamoxifen showed normal and 
undeveloped epithelium similar to negative control 
(Figure 1b). However, 70% of animals treated with 
tamoxifen + estradiol presented eosinophilic infiltration in 
the simple columnar epithelium of the lamina propria with 
moderate intensity and swollen mucosa epithelial cells 
(Figure 1c).  
Regarding morphometry of uterine epithelium in 
antiestrogen activity (Figure 1d, e and f), Sv-EtOH at all 
doses was able to inhibit the increased thickness of 
estradiol-induced uterine epithelium, behaving like 
tamoxifen alone and associated with estradiol. The group 
treated with estradiol had values significantly higher than 
the other groups (Figure 4 and Figure 1a).  
 
 
Evaluation of estrous cycle 
 
The four phases of the estrous cycle (Figure 2) were 
observed through smear vaginal realized during 30 days 
of treatment. The estrus, being the most characteristic 
phase, was regarded as the starting point of each cycle; it 
duration ranged from 1 to 7 days in this experiment. The 
number of estrous cycles recorded during 30 days for 
treated groups did not differ significantly (p>0.05) 
compared with the control group. Control average was 
6.00 ± 0.26 estrous cycles, and  groups  treated  with  Sv-
EtOH (10, 20 and 40 mg/kg) presented 5.13 ± 0.39; 4.62 
± 0.39; 4.37 ± 0.65 estrous cycles, respectively (Figure 
5). 
Cycle duration for group treated with Sv-EtOH (10, 20, 
40 mg/kg) was not significant (p>0.05), but it was 
observed that the estrous cycle length is dose 
dependent. Control group average was 4.83 ± 1.18 and 
for those treated with Sv-EtOH (10, 20, 40 mg / kg) it 
ranged from 5.57 ± 1.88, 6.16 ± 2.35, 8.16 ± 1.17, 
respectively. 
Concerning the regularity of cycles, those that 
exceeded the duration of 5 days were considered 
irregulars. The total number of estrous cycles was 159, 
with 77.36% regular and 22.64% irregular. Control group 
exhibited 87.5% of regular cycles and 12.5% of irregular 
cycles. Animals treated with Sv-EtOH (10, 20, 40 mg / kg) 
had frequencies of 73.17, 67.56 and 78.78% for regular 




Biochemical analysis  
 
During treatment with Sv-EtOH at 10, 20, 40 mg/kg for 30 
days, no clinical signs of toxicity nor mortality were 
observed. The treatment did not induce changes in the 
biochemical profile of TGP, TGO, urea,  total  cholesterol,  








H2Od + DMSO 
Treatments (Sv-EtOH) 
10 mg/kg 20 mg/kg 40 mg/kg 
TGP (U/L) 67.37 ± 4.55 55.75 ± 7.34 71.87 ± 15.4 87.00 ±14.0 
TGO (U/L)  164.8 ± 10.8 130.3 ± 64.7 98.62 ± 5.19 81.50 ± 7.9 
Urea (mg/dL) 48.25 ± 0.79 47.00 ± 1.09 46.00 ± 2.36 60.12 ± 5.9 
Creatinine (mg/dL) 0.625 ± 0.037 1.00 ± 0.05*** 0.92 ±0.05*** 0.87±0.025** 
Total cholesterol (mg/dL) 77.50 ± 33,0 56.00 ± 21.33 50.62 ± 8.12 44.37± 11.1 
Triglycerides (mg/dL) 25.37± 4.14 30.75± 3.61 31.62 ± 5.72 30.37± 5.70 
Total protein (mg/dL) 6.72 ± 0.17 6.088 ± 0.34 6.11± 0.23 5.86 ±0.075 
 




triglycerides and total protein, since the parameters were 
within the reference range, as to the values observed in 
control animals. The only exception is observed for the 
dosage of creatinine in animals treated with Sv-EtOH at 
doses of 10, 20, 40 mg/kg, which increased significantly 
at 1.00, 0.92, 0.87 (mg/dL), respectively, as compared to 
those of control animals (Table 4). 
 
 
Trial involving pregnancy and lactation  
 
Pre-implantation period  
 
The administration of Sv-EtOH (10, 20 and 40 mg/kg) 
during pre-implantation period (1st to 7th day of 
pregnancy), as compared to control, had no effect on 
body weight gain of the mother (Figure 6). 
Absolute (g) and relative masses (%) of organs (uterus, 
ovaries, kidney, adrenal, lung, heart, liver and spleen) 
from progenitor treated with extract during pre-
implantation did not differ significantly (p>0, 01) when 
compared to control (Table 5). 
Pre-implant losses, numbers of corpus luteum and 
number of deployments found in dams treated with Sv-
EtOH (10, 20 and 40 mg/kg) during pre-implantation did 





Administration of Sv-EtOH during gestation did not affect 
body weight gain of progenitor, and did not differ 
significantly from control (Figure 7). During this period, 
absolute (g) and relative masses of uterus, ovaries, 
adrenals, kidneys, lungs, heart, liver and spleen were not 
significantly different (P>0.05) (Table 7). In the 
reproductive parameters evaluated, deployment rate was 
100% for animals treated with 10 and 40 mg/kg and 
99.03% at 20 mg/kg. Females treated with 10, 20 and 40 
mg/kg had resorption rate, pre-implant loss, and post 
implant loss of 2.50 ± 1.63 to 2.60 ± 1.75; 1.56 ± 1.56 to 
2.50 ± 1.63; 1.56 ± 1.56 to 2.50 ± 1.63, respectively, not 
significantly different from control group. 
Post-implantation period (8th to 21st days of 
lactation) and evaluation of progeny 
 
Administration of Sv-EtOH, at all doses, during gestation 
did not affect body weight gain of progenitors, and did not 
differ significantly from control (Figure 8). Absolute (g) 
and relative masses (%) of organs (uterus, ovaries, 
kidneys, adrenals, lungs, heart, liver, and spleen) from 
progenitors treated with Sv-EtOH (10, 20 and 40 mg/kg) 
on post-implantation period (8th day of pregnancy to 
weaning) did not differ significantly when compared to 
control (Table 8).  
Childbirth and birth rates were 100 and 98.05%, 
respectively. Animals treated with Sv-EtOH at different 
doses in post-implementation period did not differ 
significantly in relation to pregnancy duration, number of 
born alive offspring and offspring viability compared to 
control (Figure 3). The Sv-EtOH administration during 
lactation, at all doses, interfered significantly reducing 




Evaluation of the progeny: Analysis of daily 
observations on indicative characteristics of physical 
development expected in normal offspring from mothers 
treated with Sv-EtOH (10, 20 and 40 mg/kg) for 45 days 
did not show significant differences, compared to the 





Estradiol, predominant estrogen, is synthesized on 
ovaries and secreted by granulosa cells of mature 
follicles, as well by placenta during pregnancy. Secretion 
in the systemic circulation acts on alpha and beta 
estrogen receptors. It is important to note that epithelial 
cells and uterine stroma express ER in early 
development and adulthood, and therefore both tissues 
are susceptible to estrogens in these phases (Brown et 
al., 1999; Brolio  et  al.,  2010).  Whereas,  estrogens  are  




Table 5. Evaluation of the absolute (g) and relative masses (%) of organs from progenitors 
treated with the ethanolic extract of S. versicolor during pre-deployment period (1st to 7th day) 
as compared to the control.  
 
Variables Control (n=8) 
Treatment (Sv-EtOH) 
10 mg/kg (n=8) 20 mg/kg (n=8) 40 mg/kg (n=8) 
Body weight (g) 194.08 ± 12.45 170.14 ± 4.93 171.58 ± 4.72 193.42 ± 13.21 
     
Absolute mass 
Uterus 0.412 ± 0.044 0.474 ± 0.012 0.447 ± 0.035 0.528 ± 0.049 
Kidneys 1.636 ± 0.083 1.446 ± 0.034 1.619 ± 0.079 1.562 ± 0.093 
Ovary D  0.040 ± 0.002 0.036 ± 0.001 0.031 ± 0.004 0.103 ± 0.067 
Ovary L 0.041 ± 0.005 0.039 ± 0.002 0.038 ± 0.004 0.073 ± 0.039 
Adrenal  0.084 ± 0.037 0.047 ± 0.002 0.053 ± 0.005 0.051 ± 0.005 
Lung 1.330 ± 0.086 1.234 ± 0.036 1.163 ± 0.053 1.377 ± 0.096 
Heart 0.702 ± 0.035 0.672 ± 0.015 0.650 ± 0.021 0.733 ± 0.046 
Liver 8.604 ± 0.534 8.593 ± 0.327 7.119 ± 1.075 8.405 ± 0.484 
Spleen 0.815 ± 0.121 0.897 ± 0.073 0.799 ± 0.094 0.798 ± 0.087 
     
Relative mass 
Uterus 0.204 ± 0.022 0.260 ± 0.009 0.247 ± 0.018 0.263 ± 0.015 
Kidneys  0.806 ± 0.029 0.796 ± 0.030 0.895 ± 0.030 0.782 ± 0.017 
Ovary D 0.020 ± 0.001 0.020 ± 0.001 0.017 ± 0.002 0.047 ± 0.029 
Ovary L 0.020 ± 0.002 0.022 ± 0.001 0.021 ± 0.002 0.034 ± 0.017 
Adrenal  0.042 ± 0.019 0.026 ± 0.001 0.029 ± 0.002 0.026 ± 0.003 
Lung 0.655 ± 0.037 0.676 ± 0.015 0.645 ± 0.025 0.687 ± 0.018 
Heart 0.346 ± 0.015 0.368 ± 0.006 0.361 ± 0.013 0.367 ± 0.011 
Liver  4.212 ± 0.133 4.712 ± 0.172 3.934 ± 0.578 4.226 ± 0.162 
Spleen 0.398 ± 0.055 0.494 ± 0.044 0.448 ± 0.060 0.403 ± 0.041 
 




Table 6. Effect of ethanolic extract of S. versicolor during pre-implantation (1st to 7th days) on pre-implant losses, 




10 mg/kg 20 mg/kg 40 mg/kg 
Corps luteum 9.75 ± 0.52 10.75 ± 0.81 10.62 ± 0.68 10.62 ± 0.59 
Deployments 9.12 ± 0.66 9.37 ±0.65 10.0. ±0.53 10.12 ± 0.54 
Pre-implant loss (%) 6.80 ± 2.89 12.28 ±3.51 6.39 ± 2.57 4.41 ± 2.41 
 




responsible for female secondary characteristics 
development, they also produce a suitable environment 
for fertilization, implantation, embryo nutrition and 
parturition (Lindzey and Korach, 1999). Sv-EtOH effect 
on endometrium was evaluated through uterotrophic 
assay. Within this perspective, the extract was not able to 
increase the uterus mass of rats treated at doses of 10, 
20 and 40 mg/kg, when compared to rats treated with 
estradiol alone, inferring that it has no estrogenic activity. 
However, Sv-EtOH (10, 20 and 40 mg/kg) associated 
with estradiol inhibited increase of uterus mass 
stimulated by estradiol. Similar behavior was observed in 
animals treated with estradiol association + tamoxifen, 
suggesting anti- estrogenic activity and indicating that the 
extract can prevent fertilization processes, implantation, 
embryo nutrition and childbirth. 
Hormonal effects on cervical epithelium are still limited 
on literature. Valente and Sasso (1992), studying female 
rats cervix, observed that the proportion of collagen fibers 
and infiltration of eosinophils  in  the  lamina  propria  was  






Figure 3. Evaluation of pregnancy duration (a) number of born alive 
offspring (b) and offspring viability (c) of progenitors treated with 
ethanolic extract of S. versicolor at post-deployment period (8th day 






Figure 4. Effect of Estradiol, Tamoxifen, Estradiol+Tamoxifen and Estradiol + Sv-
EtOH on the thickness of uterine epithelium of prepubertal rats.Data express 
mean ± standard error, n = 10, (One Way ANOVA / Tukey). 






Figure 5. Effect of ethanolic extract of S. versicolor on the number of estrous cycles of rats 
treated for 30 days as compared to the control. Data express mean ± standard error, n = 8, 






Figure 6. Weigh evolution of progenitors treated with the ethanolic extract of Simarouba 
versicolor during pre-deployment (1º to the 7º day of pregnancy), compared to control 







Figure 7. Weight evolution of progenitors treated with the ethanolic extract of Simarouba 
versicolor during pregnancy (1st to 20th day), compared to control. The data is expressed mean 
± SEM, n = 8, (One Way ANOVA/Tukey). 




Table 7. Evaluation the absolute (g) and relative masses (%) of organs from progenitor treated with ethanolic extract of 
Simarouba versicolor during pregnancy (1st to 20th day) as compared to the control. 
 
Variables Control (n=8) 
Treatment (Sv-EtOH) 
10 mg/kg (n=8) 20 mg/kg (n=8) 40 mg/kg (n=8) 
Body weight (g) 273.25 ± 10.91 292.1 ± 7.27 261.50 ± 5.37  241.28 ± 9.74 
     
Absolute mass 
Uterus 42.18 ± 5.019 44.47 ± 2.529 39.36 ± 2.878 45.58 ± 1.881 
Kidneys 1.470 ± 0.060 1.747 ± 0.066 1.640 ± 0.069 1.430 ± 0.044 
Ovary D  0.053 ± 0.006 0.064 ± 0.006 0.069 ± 0.003 0.050 ± 0.005 
Ovary E  0.066 ± 0.005 0.077 ± 0.006 0.061 ± 0.005 0.059 ± 0.003 
Adrenal  0.058 ± 0.005 0.056 ± 0.006 0.068 ± 0.004 0.063 ± 0.003 
Lung 1.120 ± 0.067 1.224 ± 0.104 1.393 ± 0.085 1.115 ± 0.049 
Heart 0.725 ± 0.040 0.865 ± 0.024 0.818 ± 0.029 0.783 ± 0.028 
Liver 11.81 ± 0.437 13.17 ± 0.453 12.18 ± 0.252 11.18 ± 0.495 
Spleen 0.858 ± 0.064 0.909 ± 0.032 0.977 ± 0.083 0.731 ± 0.049 
     
Relative mass 
Uterus 15.134 ± 1.50 15.26 ± 0.860 15.10 ± 1.150 18.44 ± 0.627 
kidneys 0.541 ± 0.024 0.598 ± 0.016 0.626 ± 0.018 0.595 ± 0.016 
Ovary D  0.020 ± 0.003 0.022 ± 0.002 0.027 ± 0.001 0.021 ± 0.003 
Ovary E 0.024 ± 0.001 0.026 ± 0.002 0.023 ± 0.002 0.025 ± 0.001 
Adrenal  0.022 ± 0.003 0.019 ± 0.002 0.026 ± 0.002 0.026 ± 0.001 
Lung 0.417 ± 0.037 0.415 ± 0.031 0.534 ± 0.034 0.463 ± 0.016 
Heart  0.266 ± 0.012 0.297 ± 0.009 0.313 ± 0.006 0.326 ± 0.009 
Liver 4.345 ± 0.135 4.515 ± 0.122 4.669 ± 0.100 4.646 ± 0.161 
Spleen 0.322 ± 0.036 0.312 ± 0.012 0.372 ± 0.027 0.309 ± 0.029  
 






Figure 8. Weight evolution of progenitors treated with ethanolic extract of Simarouba versicolor on post-
implantation period (8th to 21st days of pregnant) compared to control. The data is expressed mean ± SEM, 
n = 5, (One Way ANOVA / Tukey); p, *** p <0.001 vs. baseline weight 




Table 8. Evaluation absolute (g) and relative masses (%) of organs from progenitors treated with ethanolic 
extract of Simarouba versicolor on post-implantation period (8th to 21st days of pregnancy), compared to 
control. 
 
Variables Control (n=8) 
Treatment (Sv-EtOH) 
10 mg/kg (n=8) 20 mg/kg (n=8) 40 mg/kg (n=8) 
Body weight (g) 239.41 ± 14.17 209.58 ± 5.54 203.84 ± 7.81 224.71 ± 8.62 
     
Absolute mass 
Ovary D  0.039 ± 0.004 0.035 ± 0.005 0.039 ± 0.005 0.028 ± 0.002 
Ovary E 0.041 ± 0.005 1.036 ± 0.004 0.031 ± 0.005 0.046 ± 0.004 
Uterus  0.252 ± 0.033 0.237 ± 0.055 0.256 ± 0.053 0.199 ± 0.018 
Lung 1.497 ± 0.123 1.273 ± 0.065 1.240 ± 0.065 1.232 ± 0.015 
Adrenal 0.070 ± 0.005 0.064 ± 0.006 0.062 ± 0.004 0.075 ± 0.004 
kidneys 1.875 ± 0.040 1.706 ± 0.049 1.658 ± 0.064 1.912 ± 0.103 
Liver 10.55 ± 0.661 8.698± 0.299 9.942 ± 0.624 10.51 ± 0.543 
Spleen 0.565 ± 0.017 0.565 ± 0.036 0.559 ± 0.017 0.507± 0.023 
Heart 0.790 ± 0.032 0.630 ± 0.020 0.729 ± 0.034 0.621 ± 0.025 
     
Relative mass 
Ovary D  0.018 ± 0.002 0.018 ± 0.002 0.019 ± 0.002 0.015 ± 0.001 
Ovary E 0.018 ± 0.002 0.018 ± 0.002 0.016 ± 0.003 0.024 ± 0.001 
Uterus 0.114 ± 0.016 0.119 ± 0.023 0.126 ± 0.023 0.103 ± 0.010 
Lung 0.668 ± 0.024 0.651 ± 0.028 0.630 ± 0.053 0.635 ± 0.012 
Adrenal  0.032 ± 0.002 0.033 ± 0.003 0.032 ± 0.003 0.039 ± 0.002 
Kidneys  0.847 ± 0.036 0.876 ± 0.035 0.841 ± 0.061 0.983 ± 0.036 
Liver  4.721 ± 0.078 4.455 ± 0.134 5.049 ± 0.457 5.408 ± 0.206 
Spleen  0.256 ± 0.013 0.288 ± 0.013 0.282 ± 0.010 0.262 ± 0.015 
Heart 0.355 ± 0.009 0.323 ± 0.012 0.336 ± 0.014 0.320 ± 0.010 
 






Figure 9. Weight evolution of progenitors treated with ethanolic extract of Simarouba 
versicolor on lactation period (1st to 21st days of lactation) compared to control. The 
data express the mean ± standard error (ANOVA One Wa /Tukey). The data is 
expressed mean ± SEM, n = 5, (One Way ANOVA / Tukey). 




Table 9. Evaluated parameters of progeny coming from mothers treated with ethanolic extract of 
Simarouba versicolor for 45 days. 
 
Parameters (days) Control 
Treatment (Sv-EtOH) 
10 mg/kg 20 mg/kg 40 mg/kg 
Eye opening 14.40 ± 0.51 11.16 ± 2.24 14.40 ± 0.74 11.00 ± 2.77 
Detachment of ears  6.80 ± 0.37 5.83 ± 1.19 7.00 ± 0.316 5.60 ± 1.43 
Appearance of hair 6.40 ± 0.24 5.33 ± 1.08 7.40 ± 0.40 5.40 ± 1.36 
Opening of vaginal canal (females) 39.40 ± 1.03 33.53 ± 6.70 41.40 ± 2.01 31.80 ± 7.97 
 




higher in estrus phase (after hormonal peak of estrogen) 
compared to the diameter. Ramos et al. (2002) reported 
that uterine morphological aspects are related directly to 
receptors’ levels of estrogen and progesterone.  
However, analyzing histological sections of uterus in 
uterotrophic assay, animals treated with estradiol in 
endocervical canal presented simple cylindrical 
epithelium sorely infiltrated by leukocytes and stratified 
epithelium nonkeratinized with high concentration of 
eosinophils. Animals treated with tamoxifen had both 
epithelium endocervical and ectocervical underdeveloped 
compared with estradiol groups. In the treatment with 
estradiol + tamoxifen, simple cylindrical epithelium 
showed little leukocyte infiltration, low concentration of 
eosinophils and epithelia undeveloped compared to 
animals treated with estradiol alone. Likewise, it 
happened to groups treated with estradiol and Sv-EtOH 
at all doses.  
Morphological and morphometric analysis confirmed 
that the endometrium was affected by treatments in 
antiestrogenic activity assay, as animals treated with 
estradiol + tamoxifen and estradiol + Sv EtOH (10, 20 
and 40 mg/kg) presented low uterine epithelium, 
inhibiting estrogen action and confirming Sv-EtOH 
antiestrogenic activity. Events pattern in estrous cycle 
provide a useful normality indicator for neuroendocrine 
function of non-pregnant female ovaries (Andrews et al.; 
2002). Sv-EtOH treatment (10, 20 and 40 mg/kg) for 30 
consecutive days did not cause changes in regularity, 
duration and repeatability of estrous cycles as compared 
to the control. This indicates that the treatment did not 
promote disorders of hypothalamic-pituitary-ovarian axis. 
Estrous cycle in female rats is regular, consists of 
several annual cycles and with 4 to 5 days of duration 
(Cobea, 1996). Due to this short period, rats are 
considered the ideal animals to study estrous cycle 
variations (Marcondes et al., 2001). However, control 
animals may show irregular cycles, usually in the form of 
cycle stretching or acyclicity (US EPA, 1996). In this 
study, control rats showed cycle elongation (1 day for 
treated groups). Although the difference between the 
groups was not significant (p >0.05), there is a dose-
dependent tendency to increase cycles duration. So far, 
all cycles in the 30 days consecutive period  of  treatment 
were in accordance with the literature (Santos et al., 
2003; Hollenbach et al., 2008). 
Cycle changes can be caused by treatment with certain 
substances, such as xenobiotics, that can induce 
acyclicity characterized by persistent estrus, diestrus or 
irregular standard (Goldman et al., 2007). Some changes 
in ovarian hormones and extra-ovarian can lead to 
irregularity in ovarian function causing changes in estrous 
cycle duration (Shivalingappa et al., 2002). 
Alterations in estrous cycle extension can be a 
response to exposure to an agent with estrogenic 
property or capable of blocking ovulation. On the other 
hand, there are substances that can induce changes in 
estrous cycle at doses that do not impair fertility. Diestrus 
persistence indicates temporary or permanent 
interruption of follicular development and ovulation, 
inducing temporary infertility. Prolonged diestrus or 
anoestrus can be indicative agents (for example, 
polycyclic aromatic hydrocarbons) that interfere with 
follicle development or deplete the pool of primordial 
follicles or agents such as atrazine, which interrupt 
support of ovarian gonadotropin (US EPA, 1996; 
Romero, 2007). In this experiment, it was observed that 
in irregular cycles, the phase that lasted more was 
diestrous (72.2%); it is characterized by the lack of 
cellular elements and high concentrations of leucocytes 
and mucus. Estrus phase lasted for more than 12 h in 
22.2% cases. 
Hematological evaluation represents an important area 
of study on animals’ health. Blood analysis helps in the 
diagnosis and prognosis of various diseases (Jain, 1993). 
Evaluation of systemic toxicity showed that oral 
administration of Sv-EtOH at doses of 10, 20 and 40 
mg/kg for 30 days produced no behavioral changes in 
adult Wistar rats nor visible signs of toxicity. Chemistry 
profile parameters evaluated were within the normal 
range except for creatinine levels. There was a 
quantitative increase in creatinine concentration for all 
groups exposed to Sv-EtOH as compared to the control 
group. Creatinine is an important parameter for diagno-
sing various kidney problems. Creatinine is a non-protein 
nitrogenous organic compound formed from the 
dehydration of the muscle creatine. This serves to assess 
glomerular filtration rate, as blood concentration increases  




with reduced renal filtration rate. The presence of this 
substance in blood can be used to identify renal 
disorders. Creatinine tends to increase slower than urea 
in renal disease. Thus, this parameter provides us with 
evidence of renal impairment in animals treated with Sv-
EtOH. 
Deployment is a process by which the embryo has 
intimate physical and physiological contact with maternal 
endometrium to establish pregnancy. Although there are 
variations of this process between species, certain basic 
events are similar. The fundamental characteristic of this 
process is the synchronized embryo development to the 
blastocyst stage and differentiation from uterus to 
receptive state. This is followed by interactions between 
activated blastocysts and the uterine epithelium to start 
deployment (Muller et al., 2009). 
Progenitors exposed to Sv-EtOH (10, 20 and 40 mg/kg) 
during pre-implantation period did not alter weight gain. 
Reduction in corporal mass could reflect a variety of 
responses, including anorexia induced by the treatment 
or systemic toxicity (US EPA, 1996). In relation to 
absolute and relative masses of ovaries, uterus, liver, 
lungs, spleen, kidneys, heart and adrenal did not exhibit 
significant changes. There were also no physical and 
macroscopic changes in animals and organs exposed to 
Sv-EtOH. These results indicate absence of extract 
toxicity at investigated doses, during this period, which is 
probably due to short term exposure. 
Gestational period is one of the most sensitive stages 
of reproductive cycle, which results in important 
responses. Today, it is known that in this period most 
agents cross through the placenta. Thus, it can be 
considered that maternal exposure to external agents 
may result in significant effects on a passive organism, a 
secondary target of these agents, which is the embryo 
body (Damasceno et al., 2008). During pregnancy, the 
exposure of mothers to the ethanol extract of S. 
versicolor at all doses did not affect the body mass gain 
or the absolute and relative masses of organs (uterus, 
ovaries, liver, heart, lung, spleen, kidney and adrenal 
glands). Resorption rates, pre-implant loss and post-
implant loss were not significant compared to control 
results. Groups treated with Sv-EtOH presented 
implantation rates of 100%, indicating absence of 
maternal toxicity at doses investigated during pregnancy. 
Also no macroscopic signs of toxicity were observed in 
animals or organs. 
The evaluation of absolute masses of metabolism and 
excretion organs is important, since liver and kidney are 
responsible for metabolism and elimination of xenobiotics 
intoxication cases, which may lead to an increase in 
mass (Mello, 2007). In post-implantation period, 
progenitors exposed to Sv-EtOH during gestation and 
lactation did not show changes in absolute and relative 
masses of organs (uterus, ovaries, liver, heart, lung, 
spleen, kidneys and adrenals), not differing from control 





of progenitors treated during gestation, compared to 
control animals, indicating absence of maternal toxicity in 
the doses investigated.  
The same way, during pregnancy and lactation there 
were no signs of toxicity such as anorexia, shivers, 
diarrhea, piloerection or seizures. Rats’ exposure to Sv-
EtOH at different doses did not affect childbirth index (%) 
and birth index (%), indicating the extract is not toxic to 
prenatal development. Variations in gestation duration 
can result in alteration in childbirth labor. A significant 
prolongation of gestation time can be the cause of failure 
during childbirth mechanism and can result in death or 
injury of brood per dystocia. 
Exposure in late pregnancy to substances with anti-
estrogenic activity can interfere in estrogen action, 
altering both characteristics structurally and sensitivity of 
myometrium cells to promote childbirth (Lindzey and 
Korach, 1999). Administration of Sv-EtOH, at tested 
doses, did not affect pregnancy duration, number of born 
alive (cubs alive until the fourth day) and offspring 
viability. In this way, Sv-EtOH antiestrogenic activity did 
not impair estradiol action to increase oxytocin 
expression. It did not inhibit the production of 
prostaglandins in uterus in late pregnancy and did not 
also interfere in childbirth labor in rats treated with the 
extract.  
Sv-EtOH at the tested doses, during lactation affected 
weight gain when compared to control animals. This may 
be an indication of toxicity but also by caloric burn in 
parturition and lactation periods. Although results indicate 
a possible extract systemic toxicity, exposure at doses 
investigated in pregnancy and lactation periods did not 
affect the overall development of offspring (detachment 
period of ears, fur appearance, eye opening, opening of 
vaginal canal and offspring viability) when compared with 
control group. Although, exposure route has been altered 
from fetal-placental membrane to breast milk, indicating a 
possible reduction in exposure levels to the extract 
components; it also suggests lack of toxicity in postnatal 
development because descendants of the progenitors 
treated with the extract. 
Therefore, the ethanol extract of S. versicolor 
presented antiestrogen activity, possible systemic toxicity 
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